Drugs / Illuminate Cream
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02730819 | May → Dec 2016 | hyperpigmentation of the skin | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Illuminate Cream | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02730819 ↗ |
| Modality | Other / unclassified | “Illuminate Cream is a skin-lightening formulation containing multiple drugs, including a retinoid, calcineurin inhibitor, anti-tyrosinase agent and sunscreen microfine zinc oxide.” NCT02730819 ↗ |
| Route | Topical | “Approximately 0.5 grams to be applied topically to affected areas of skin once per day for 20 weeks.” NCT02730819 ↗ |